Dashboard
Portfolios
Watchlist
Community
Discover
Screener
Narratives
Your Valuation
Community
/
South Africa
/
Pharmaceuticals & Biotech
Create a narrative
Aspen Pharmacare Holdings Community
JSE:APN Community
1
Narratives
written by author
0
Comments
on narratives written by author
34
Fair Values set
on narratives written by author
Create a narrative
Aspen Pharmacare Holdings
Popular
Undervalued
Overvalued
Community Investing Ideas
Aspen Pharmacare Holdings
AN
AnalystConsensusTarget
Consensus Narrative from 5 Analysts
Commercial Pharma And GLP-1 Expansion Will Empower Future Progress
Key Takeaways Steady commercial pharma growth through strategic market focus in China and Russia enhances revenue stability. GLP-1 and insulin manufacturing expansion offers substantial long-term revenue and margin growth potential.
View narrative
R157.26
FV
22.6% undervalued
intrinsic discount
4.25%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
18
users have followed this narrative
Updated
narrative
Your Valuation for
APN
APN
Aspen Pharmacare Holdings
Your Fair Value
R
Current Price
R121.75
136.4% overvalued
intrinsic discount
Growth estimate over
Annual revenue growth rate
5 Years
time period
%/yr
Decrease
Increase
Past
Future
0
58b
2015
2018
2021
2024
2025
2027
2030
Revenue R57.8b
Earnings R5.7b
Advanced
Set Fair Value